RARA and adenosarcoma: STED2 and RARA, which are known to be recurrently mutated in PTs and are potentially related to their development, were not mutated in adenosarcomas, but these differences did not reach statistical significance (23% vs 0, P = 0.0506; 18% vs 0, P = 0.1105, respectively, Fisher's exact tests).